Humana Inc. vs UnitedHealth Group Incorporated: Strategic Comparison

This in-depth comparison examines Humana Inc. and UnitedHealth Group Incorporated across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Humana Inc. on its own, evaluating UnitedHealth Group Incorporated, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Humana Inc. and UnitedHealth Group Incorporated is widest.

On the headline numbers, Humana Inc. reports annual revenue of $129.7B against $447.6B for UnitedHealth Group Incorporated, while their respective market capitalizations stand at $48.2B and $450.0B. Humana Inc. is headquartered in United States and UnitedHealth Group Incorporated operates from United States, and those different home markets shape how each company competes.

Humana Inc.: Humana Inc. is a Fortune 50 health company headquartered in Louisville, Kentucky. It serves roughly 7.2 million individual and group Medicare Advantage members, millions of stand-alone Part D, Medicaid, and TRICARE beneficiaries, and patients of its CenterWell clinics, pharmacy, and home health services. Unlike diversified rivals, Humana gets nearly all of its medical membership from government-funded programs, so it is effectively a bet on Medicare Advantage and senior care.

UnitedHealth Group Incorporated: UnitedHealth is best understood as a healthcare operating system: insurance premiums and claims create scale, Optum manages pharmacy and care services, and data flows help price risk, coordinate care, and manage cost.

Humana Inc. and UnitedHealth Group Incorporated pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Humana Inc. and UnitedHealth Group Incorporated.

Humana Inc. business model: Humana runs two reporting segments. The Insurance segment sells individual and group Medicare Advantage plans, stand-alone Medicare Part D drug plans, state Medicaid contracts, and administers TRICARE for the Defense Health Agency. It is paid largely by the federal government on a per-member, per-month basis adjusted for each member's health risk, and keeps the difference between those premiums and medical and pharmacy claims plus operating costs. The CenterWell segment provides services: CenterWell Senior Primary Care clinics, CenterWell Pharmacy (mail-order and specialty), and CenterWell Home Health. CenterWell serves Humana members and members of other plans, and it gives Humana direct influence over care costs for its own seniors.

UnitedHealth Group Incorporated business model: UnitedHealth makes money in two connected ways. UnitedHealthcare collects premiums from employers, individuals and government programs (Medicare Advantage and Medicaid) and earns fees for administering self-funded employer plans; profit depends on keeping medical costs below premiums. Optum sells services: Optum Rx runs pharmacy benefit management and specialty pharmacy, Optum Health delivers primary, specialty and home care (often under value-based contracts that pay a fixed amount per patient), and Optum Insight sells data, analytics, claims and revenue-cycle technology. Optum serves UnitedHealthcare and outside payers, so some dollars UnitedHealthcare pays out return as Optum revenue. Premiums from CMS programs made up 44% of 2025 consolidated revenue.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Humana Inc. stack up against those of UnitedHealth Group Incorporated.

Humana Inc. competitive advantage: Humana's edge is depth in one market. It is the second-largest Medicare Advantage insurer after UnitedHealth, it has decades of experience pricing senior risk, and it owns care-delivery assets built for seniors: CenterWell Senior Primary Care clinics, a large mail-order pharmacy, and CenterWell Home Health. Owning those services lets Humana manage chronic conditions and pharmacy spending directly instead of only paying claims. The tradeoff is concentration: unlike UnitedHealth, CVS/Aetna, or Elevance, it has no large commercial or PBM business to offset a bad Medicare year.

UnitedHealth Group Incorporated competitive advantage: UnitedHealth's advantage is vertical integration. It combines the largest U.S. health insurer with Optum's pharmacy, care delivery, data, analytics, and services assets, giving it scale in claims, benefits, networks, prescriptions, and care management.

Future prospects matter as much as current results. The growth strategies below explain how Humana Inc. and UnitedHealth Group Incorporated each plan to expand from here.

Humana Inc. growth strategy: Humana's strategy under Jim Rechtin is to grow Medicare Advantage membership while rebuilding margins and quality scores. Key moves include completing the exit from employer-group commercial medical coverage in 2025, adding more than 1 million MA members for 2026, pruning about 600,000 members' worth of underperforming plans for 2027, investing in Star Ratings operations, and expanding CenterWell Senior Primary Care and CenterWell Pharmacy so that more member care runs through Humana-owned services. It is also bidding for and growing state Medicaid contracts, with a focus on members eligible for both Medicare and Medicaid.

UnitedHealth Group Incorporated growth strategy: UnitedHealth is focused on pricing and benefit design, medical cost management, Medicare Advantage discipline, Medicaid and employer offerings, Optum Rx scale, Optum Health care delivery, technology, data analytics, and value-based care capabilities.

A closer look at the financial trajectory of Humana Inc. and UnitedHealth Group Incorporated rounds out the comparison.

Humana Inc.: Humana's revenue grew from $54.4 billion in 2016 to $129.66 billion in 2025, driven by Medicare Advantage enrollment and higher per-member payments. Profit moved the other way: net income fell from $3.37 billion in 2020 to $1.21 billion in 2024 and $1.19 billion in 2025 as medical costs rose faster than payments. In 2026 revenue is growing fast again: Q2 2026 revenue was $40.89 billion, up 26.2% year over year, with GAAP EPS of $5.73 and adjusted EPS of $7.61. Year-to-date operating cash flow reached $3.22 billion. Full-year 2026 guidance is adjusted EPS of at least $9.00 and GAAP EPS of at least $6.52, reflecting the Star Ratings bonus headwind.

UnitedHealth Group Incorporated: UnitedHealth Group grew 2025 revenue 12% to $447.6 billion, yet earnings from operations fell from $32.3 billion in 2024 to $19.0 billion as Medicare Advantage and Optum Health medical costs ran well above pricing. Net margin was 2.7% and operating cash flow was $19.7 billion. 2026 is a repair year: management guided to more than $439 billion in revenue, a slight decline from planned right-sizing of membership, and after a Q2 with $112.0 billion revenue, $8.0 billion operating earnings and an 86.7% adjusted medical care ratio, raised adjusted EPS guidance to $19.50 to $20.00.